Jeffrey M. Dayno Harmony Biosciences Holdings, Inc. (HRMY) insider trading activity

HRMY Quotes by TradingView

Jeffrey M. Dayno is PRESIDENT, CEO of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 5,933 shares of HRMY, which is worth approximately $205,044. The most recent transaction as insider was on Jan 24, 2025, when has been sold 4,567 shares (Common Stock) at a price of $38.01 per share, resulting in proceeds of $173,591. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.93K
Infinity% 3M change
Infinity% 12M change
Total Value Held $205,044

Jeffrey M. Dayno Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2025
SELL
Payment of exercise price or tax liability
$173,591 $38.01 p/Share
4,567 Reduced 43.5%
5,933 Common Stock
Jan 24 2025
BUY
Exercise of conversion of derivative security
-
10,500 Added 50.0%
10,500 Common Stock
Jan 21 2025
SELL
Open market or private sale
$774,228 $40.13 p/Share
19,293 Reduced 100.0%
0 Common Stock
Jan 21 2025
BUY
Exercise of conversion of derivative security
$158,588 $8.22 p/Share
19,293 Added 50.0%
19,293 Common Stock
Nov 03 2022
SELL
Open market or private sale
$900,300 $60.02 p/Share
15,000 Reduced 100.0%
0 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$123,300 $8.22 p/Share
15,000 Added 50.0%
15,000 Common Stock
Nov 01 2022
SELL
Open market or private sale
$826,500 $55.1 p/Share
15,000 Reduced 100.0%
0 Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
$123,300 $8.22 p/Share
15,000 Added 50.0%
15,000 Common Stock
Oct 19 2021
SELL
Open market or private sale
$790,790 $43.45 p/Share
18,200 Reduced 100.0%
0 Common Stock
Oct 19 2021
BUY
Exercise of conversion of derivative security
$149,604 $8.22 p/Share
18,200 Added 81.61%
4,101 Common Stock
Oct 06 2021
SELL
Open market or private sale
$72,180 $40.1 p/Share
1,800 Reduced 100.0%
0 Common Stock
Oct 06 2021
BUY
Exercise of conversion of derivative security
$14,796 $8.22 p/Share
1,800 Added 50.0%
1,800 Common Stock
Sep 07 2021
SELL
Open market or private sale
$375,800 $37.58 p/Share
10,000 Reduced 100.0%
0 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$82,200 $8.22 p/Share
10,000 Added 50.0%
10,000 Common Stock
Aug 27 2021
SELL
Open market or private sale
$275,690 $35.16 p/Share
7,841 Reduced 100.0%
0 Common Stock
Aug 27 2021
BUY
Exercise of conversion of derivative security
$64,453 $8.22 p/Share
7,841 Added 50.0%
7,841 Common Stock
Aug 26 2021
SELL
Open market or private sale
$75,587 $35.01 p/Share
2,159 Reduced 100.0%
0 Common Stock
Aug 26 2021
BUY
Exercise of conversion of derivative security
$17,747 $8.22 p/Share
2,159 Added 50.0%
2,159 Common Stock
Aug 10 2021
SELL
Open market or private sale
$300,589 $30.21 p/Share
9,950 Reduced 100.0%
0 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$81,789 $8.22 p/Share
9,950 Added 50.0%
9,950 Common Stock
Jul 22 2021
SELL
Open market or private sale
$1,500 $30.0 p/Share
50 Reduced 100.0%
0 Common Stock
Jul 22 2021
BUY
Exercise of conversion of derivative security
$411 $8.22 p/Share
50 Added 50.0%
50 Common Stock
JMD

Jeffrey M. Dayno

PRESIDENT, CEO
Plymouth Meeting, PA

Track Institutional and Insider Activities on HRMY

Follow Harmony Biosciences Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

News

Receive news related to Harmony Biosciences Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRMY